ALDNF: AI 评分 44/100 — AI 分析 (4月 2026)

Aladdin Healthcare Technologies SE focuses on developing software solutions for health information management using blockchain technology. The company specializes in AI-driven platforms for early disease diagnosis, health risk assessment, and drug discovery.

Key Facts: AI Score: 44/100 Sector: Healthcare

公司概况

概要：

Aladdin Healthcare Technologies SE, based in Germany, develops AI and blockchain-based healthcare solutions, including platforms for early disease diagnosis, risk assessment, and drug discovery. Operating in the healthcare information services sector, the company targets chronic diseases using advanced predictive data analytics.

ALDNF是做什么的？

Founded in 2014 and headquartered in Berlin, Germany, Aladdin Healthcare Technologies SE operates through its subsidiary, Aladdin Healthcare Technologies Ltd, focusing on the intersection of healthcare and advanced technology. The company develops software solutions for health information storage and management, leveraging blockchain technology to ensure data security and integrity. Aladdin specializes in technologies such as blockchain, machine learning, and artificial intelligence to create innovative healthcare platforms. Its core offerings include the Artificial Intelligence Early Diagnosis platform, designed for brain imaging analysis, the Health Risk Assessment platform, which assesses the risk of cardiovascular, diabetes, and kidney-related diseases, and the Artificial Intelligence assisted Drug Discovery platform, aimed at identifying small molecule drug compounds for age-related diseases like Alzheimer's, Parkinson's, and SARS-CoV-2. By using blockchain, machine learning, AI, and advanced predictive data analytics, Aladdin aims to facilitate the early diagnosis of chronic diseases, improving patient outcomes and reducing healthcare costs. The company's focus on AI and blockchain positions it as a player in the evolving landscape of healthcare technology.

ALDNF的投资论点是什么？

Aladdin Healthcare Technologies SE presents a speculative investment opportunity within the healthcare information services sector. The company's focus on AI and blockchain technologies for early disease diagnosis and drug discovery could drive future growth, although the company's small size and OTC listing present significant risks. Key value drivers include successful development and commercialization of its AI-powered platforms, particularly the Early Diagnosis and Drug Discovery platforms. Upcoming catalysts include potential partnerships with healthcare providers and pharmaceutical companies to deploy its technologies. However, investors should be aware of the risks associated with OTC-listed companies, including limited liquidity and disclosure.

ALDNF在哪个行业运营？

Aladdin Healthcare Technologies SE operates within the healthcare information services industry, a sector experiencing rapid growth due to the increasing adoption of digital health solutions and the need for efficient data management. The market is driven by factors such as the rising prevalence of chronic diseases, the growing demand for personalized medicine, and advancements in AI and machine learning. Competitors include companies like Applied Therapeutics Inc (APTCF), and MedMira Inc (MMNFF). Aladdin's focus on blockchain and AI differentiates it within this competitive landscape.

Medical - Healthcare Information Services

Healthcare

ALDNF有哪些增长机遇？

Expansion of AI-Powered Diagnostic Platforms: Aladdin Healthcare Technologies SE has the opportunity to expand its AI-powered diagnostic platforms for early disease detection. The global AI in healthcare market is projected to reach $95 billion by 2030, offering a substantial market for Aladdin's AI Early Diagnosis platform. Successful development and deployment of these platforms could drive significant revenue growth.
Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with hospitals, clinics, and other healthcare providers can accelerate the adoption of Aladdin's technologies. These partnerships can provide access to larger patient populations and facilitate the integration of Aladdin's platforms into existing healthcare workflows. Successful partnerships could lead to recurring revenue streams and increased market penetration.
Drug Discovery Platform Commercialization: Aladdin's AI-assisted Drug Discovery platform presents a significant growth opportunity. The global drug discovery market is expected to reach $81.3 billion by 2028. By identifying promising drug candidates for age-related diseases, Aladdin can generate revenue through licensing agreements or the development of its own drug pipeline.
Geographic Expansion into New Markets: Aladdin Healthcare Technologies SE can expand its operations into new geographic markets, particularly in regions with growing healthcare expenditures and increasing adoption of digital health technologies. Emerging markets in Asia and Latin America offer significant growth potential for Aladdin's AI and blockchain-based solutions. Expansion into these markets can diversify revenue streams and reduce reliance on the European market.
Integration of Blockchain for Data Security: Leveraging blockchain technology to enhance data security and privacy can attract healthcare providers and patients concerned about data breaches and regulatory compliance. The blockchain in healthcare market is projected to reach $1.6 billion by 2027. By offering secure and transparent data management solutions, Aladdin can differentiate itself from competitors and gain a competitive advantage.

Aladdin Healthcare Technologies SE operates in the healthcare information services sector, focusing on AI and blockchain technologies.
The company's P/E ratio is -0.22, reflecting its current lack of profitability.
Aladdin Healthcare Technologies SE has a beta of 0.55, indicating lower volatility compared to the market.
The company develops AI-powered platforms for early disease diagnosis, health risk assessment, and drug discovery.
Aladdin Healthcare Technologies SE employs 3 people, reflecting its small scale of operations.

ALDNF提供哪些产品和服务？

Develops software solutions for health information storage and management.
Utilizes blockchain technology for secure data handling.
Specializes in artificial intelligence and machine learning applications in healthcare.
Creates AI-powered platforms for early disease diagnosis.
Offers health risk assessment tools for cardiovascular, diabetes, and kidney-related diseases.
Develops AI-assisted drug discovery platforms for age-related diseases.

ALDNF如何赚钱？

Develops and licenses AI-powered healthcare platforms to hospitals and clinics.
Generates revenue through software subscriptions and licensing fees.
Partners with pharmaceutical companies for drug discovery and development.
Provides data analytics services to healthcare providers.

Hospitals and clinics seeking to improve diagnostic accuracy and efficiency.
Pharmaceutical companies looking for AI-driven drug discovery solutions.
Healthcare providers aiming to enhance patient risk assessment and management.
Research institutions interested in AI-based healthcare data analysis.

Proprietary AI algorithms for early disease diagnosis.
Blockchain technology for secure and transparent data management.
Expertise in healthcare data analytics and machine learning.
Strategic partnerships with healthcare providers and research institutions.

什么因素可能推动ALDNF股价上涨？

Upcoming: Potential partnerships with healthcare providers to implement AI diagnostic platforms.
Upcoming: Development and launch of new AI-powered healthcare solutions.
Ongoing: Continued research and development in AI-assisted drug discovery.
Ongoing: Expansion of blockchain technology for secure data management.

ALDNF的主要风险是什么？

Potential: Intense competition from larger healthcare technology companies.
Potential: Regulatory hurdles and compliance requirements in the healthcare industry.
Potential: Data security and privacy concerns related to patient information.
Ongoing: Limited liquidity and high volatility due to OTC listing.

ALDNF的核心优势是什么？

Innovative AI-powered platforms for early disease diagnosis.
Secure data management using blockchain technology.
Focus on addressing chronic diseases with high prevalence.
Potential for partnerships with healthcare providers and pharmaceutical companies.

ALDNF的劣势是什么？

Small company size and limited resources.
Dependence on successful development and commercialization of new technologies.
Limited operating history and track record.
OTC listing with associated liquidity and disclosure risks.

ALDNF有哪些机遇？

Expanding into new geographic markets with growing healthcare expenditures.
Forming strategic alliances with hospitals and research institutions.
Leveraging AI and machine learning to enhance drug discovery.
Capitalizing on the increasing adoption of digital health solutions.

ALDNF面临哪些威胁？

Intense competition from larger and more established healthcare technology companies.
Regulatory hurdles and compliance requirements in the healthcare industry.
Data security and privacy concerns related to patient information.
Potential for technological obsolescence and disruption.

ALDNF的竞争对手是谁？

Applied Therapeutics Inc — Focuses on developing novel therapeutics for unmet medical needs. — (APTCF)
Edene Biotechnology Co Ltd — Develops and commercializes innovative biotechnology products. — (EDNEF)
MedMira Inc — Develops and manufactures rapid diagnostic tests. — (MMNFF)
Muraviev Technologies Inc — Focuses on developing innovative technologies for various industries. — (MRVT)
On Track Innovations Ltd — Provides cashless payment solutions and identification systems. — (OTRKQ)

Key Metrics

MoonshotScore: 44/100

Company Profile

CEO: Wade Menpes-Smith
Headquarters: Berlin, DE
Employees: 3
Founded: 2021

AI Insight

AI analysis pending for ALDNF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Aladdin Healthcare Technologies SE do?

Aladdin Healthcare Technologies SE develops and commercializes AI-powered platforms for early disease diagnosis, health risk assessment, and drug discovery. The company leverages blockchain technology for secure data management and focuses on addressing chronic diseases with high prevalence. Aladdin's solutions target healthcare providers, pharmaceutical companies, and research institutions seeking to improve diagnostic accuracy, enhance patient care, and accelerate drug development. The company operates in the healthcare information services sector and aims to capitalize on the growing demand for digital health solutions.

What do analysts say about ALDNF stock?

As of 2026-03-18, there is no available analyst coverage for ALDNF stock. Given its OTC Other listing and small market capitalization, the stock is unlikely to be followed by major research firms. Investors should conduct their own independent research and due diligence before making any investment decisions. Key valuation metrics, such as price-to-earnings ratio and price-to-sales ratio, may not be meaningful due to the company's current lack of profitability and limited revenue generation. Growth considerations include the successful development and commercialization of its AI-powered platforms and the formation of strategic partnerships.

What are the main risks for ALDNF?

The main risks for Aladdin Healthcare Technologies SE include limited liquidity due to its OTC listing, lack of regulatory oversight, and potential for fraud or manipulation. The company also faces intense competition from larger and more established healthcare technology companies, as well as regulatory hurdles and compliance requirements in the healthcare industry. Data security and privacy concerns related to patient information pose additional risks. Furthermore, the company's dependence on successful development and commercialization of new technologies makes it vulnerable to technological obsolescence and disruption.